CN101843647B - Chinese medicament for treating angina - Google Patents

Chinese medicament for treating angina Download PDF

Info

Publication number
CN101843647B
CN101843647B CN2009102354870A CN200910235487A CN101843647B CN 101843647 B CN101843647 B CN 101843647B CN 2009102354870 A CN2009102354870 A CN 2009102354870A CN 200910235487 A CN200910235487 A CN 200910235487A CN 101843647 B CN101843647 B CN 101843647B
Authority
CN
China
Prior art keywords
chinese medicine
chinese medicament
fine powder
chinese
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009102354870A
Other languages
Chinese (zh)
Other versions
CN101843647A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunlon Pharmaceutical Co., Ltd.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102354870A priority Critical patent/CN101843647B/en
Publication of CN101843647A publication Critical patent/CN101843647A/en
Application granted granted Critical
Publication of CN101843647B publication Critical patent/CN101843647B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: costustoot, Szechuan lovage rhizome, radix pseudo-ginseng, lucid ganoderma and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, and activating blood, dissolving stasis and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

The anginal Chinese medicine of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Present be intended to treat the anginal field of Chinese medicines, exist some problems: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many patient with angina pectoris are subjected to the torment of feeling of oppression and pain in the chest for a long time, the probability that myocardial infarction takes place increases, and has influenced life quality.
At problem set forth above, the invention provides the anginal Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the anginal Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Aucklandiae 3-20 part Rhizoma Chuanxiong 4-30 part Radix Notoginseng 3-20 part
Ganoderma 2-15 part
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Radix Aucklandiae, Rhizoma Chuanxiong are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma vigorate qi and replenish the blood in the side, tranquilizing by nourishing the heart has the body resistance strengthening and constitution consolidating, regulates the effect of immunity of organisms; Be aided with Rhizoma Chuanxiong, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Assistant is with pain relieving in the Radix Aucklandiae circulation of qi promoting profit.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Radix Aucklandiae 60 gram Rhizoma Chuanxiongs 80 gram Radix Notoginseng 60 grams
Ganoderma 40 grams
Weight in accordance with regulations, with conventional water extraction process the Radix Aucklandiae, Rhizoma Chuanxiong perfume are extracted, make extractum fine powder 42 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Radix Aucklandiae 120 gram Rhizoma Chuanxiongs 160 gram Radix Notoginseng 100 grams
Ganoderma 80 grams
By above-mentioned same method, make 942 of Chinese medicinal capsules, close Chinese medicine fine powder and extract 0.28 gram in every capsules.
3, get following prescription (weight is unit by gram):
The Radix Aucklandiae 200 gram Rhizoma Chuanxiongs 300 gram Radix Notoginseng 180 grams
Ganoderma 150 grams
By above-mentioned same method, make 1714 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 9 portions of Radix Notoginseng of 7 parts of Rhizoma Chuanxiongs of the Radix Aucklandiae
4 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 30 portions of Radix Notoginseng of 15 parts of Rhizoma Chuanxiongs of the Radix Aucklandiae
12 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science angina pectoris, through 7 routine clinical observations.Selecting the tcm diagnosis angina pectoris is standard: feeling of oppression and pain in the chest, and nervous cardiopalmus, limbs fatigue, the visible T ripple of electrocardiogram is unusual during outbreak.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 51 years old-82 years old, 66.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and heart district is comfortable, and angor uncomfortable in chest is obviously alleviated or disappeared, and Electrocardioscopy is no abnormal.
2, effective: body constitution strengthens to some extent, and angor uncomfortable in chest is alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. the anginal Chinese medicine of treatment adopts the raw material of Chinese medicine preparation, and it is characterized in that: it is to make with the component of following weight ratio:
Radix Aucklandiae 3-20 part Rhizoma Chuanxiong 4-30 part Radix Notoginseng 3-20 part
Ganoderma 2-15 part
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Radix Aucklandiae, Rhizoma Chuanxiong are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102354870A 2009-10-16 2009-10-16 Chinese medicament for treating angina Active CN101843647B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102354870A CN101843647B (en) 2009-10-16 2009-10-16 Chinese medicament for treating angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102354870A CN101843647B (en) 2009-10-16 2009-10-16 Chinese medicament for treating angina

Publications (2)

Publication Number Publication Date
CN101843647A CN101843647A (en) 2010-09-29
CN101843647B true CN101843647B (en) 2011-06-29

Family

ID=42768582

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102354870A Active CN101843647B (en) 2009-10-16 2009-10-16 Chinese medicament for treating angina

Country Status (1)

Country Link
CN (1) CN101843647B (en)

Also Published As

Publication number Publication date
CN101843647A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843661B (en) Chinese medicament for treating angina
CN101843712B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101554443B (en) Traditional Chinese medicine for treating angina
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843753B (en) Chinese medicament for treating angina
CN101843644B (en) Chinese medicament for treating tachycardia
CN101843647B (en) Chinese medicament for treating angina
CN101843720B (en) Chinese medicament for treating angina
CN101850034B (en) Chinese medicament for treating angina
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843645B (en) Chinese medicament for treating tachycardia
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843758B (en) Chinese medicament for treating coronary disease
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843792A (en) Chinese medicament for treating angina
CN101897808A (en) Traditional Chinese medicine for treating angina pectoris
CN101843698A (en) Chinese medicament for treating cervical spondylosis
CN101843646A (en) Chinese medicament for treating tachycardia
CN101843730A (en) Chinese medicament for treating coronary disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130710

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130710

Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180202

Address after: 409800 Chongqing city Youyang County plate brook light industrial park, 2 A

Patentee after: Chongqing Wanyuan Pharmaceutical Co., Ltd.

Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180309

Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd.

Address before: 409800 Chongqing city Youyang County plate brook light industrial park, 2 A

Patentee before: Chongqing Wanyuan Pharmaceutical Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180507

Address after: 065201 Hebei province Sanhe Yanjiao Development Zone Yan Chang Road 239, long long Pharmaceutical Co., Ltd.

Patentee after: Sunlon Pharmaceutical Co., Ltd.

Address before: 226500 twenty-four groups of moving villages in Rugao City, Jiangsu Province

Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd.